NUCLEUS? HYBRID S12 CI24RE (S12) NA

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2020-01-03 for NUCLEUS? HYBRID S12 CI24RE (S12) NA manufactured by Cochlear Ltd.

Event Text Entries

[173448841] This report is submitted on january 3, 2020.
Patient Sequence No: 1, Text Type: N, H10


[173448842] Per the clinic, the patient experienced poor performance with the device. Reprogramming attempts were made; however, the issue could not be resolved. The device was explanted (b)(6) 2019 and the patient was reimplanted with a new device during the same surgery.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number6000034-2020-00051
MDR Report Key9542240
Date Received2020-01-03
Date of Report2019-12-12
Date of Event2019-11-21
Report Date2020-01-03
Date Reported to FDA2020-01-03
Date Reported to Mfgr2019-12-12
Date Added to Maude2020-01-03
Event Key0
Report Source CodeDistributor report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNUCLEUS? HYBRID S12
Generic NameNUCLEUS 24 COCHLEAR IMPLANT SYSTEM
Product CodePGQ
Date Received2020-01-03
Model NumberCI24RE (S12)
Catalog NumberNA
Lot NumberNA
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerCOCHLEAR LTD
Manufacturer Address1 UNIVERSITY AVENUE MACQUARIE UNIVERSITY, 2109 AS 2109


Patients

Patient NumberTreatmentOutcomeDate
101. Required No Informationntervention 2020-01-03

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.